10-Decarbomethoxyaclacinomycine A

10-Decarbomethoxyaclacinomycin A is an anthracycline antibiotic can be produced by Streptomyces galilaeus MA144-Mlt mutant strain KE303. 10-Decarbomethoxyaclacinomycin A has antibacterial activities[1].

76264-91-0

12352005

Antibiotic; Bacterial

Anti-infection

COVID-19-immunoregulation

Cancer; Infection

OC1=C(C(C2=C(O)C=CC=C2C3=O)=O)C3=CC(C[C@](O)(C4)CC)=C1[C@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@@H]7O[C@H](C(CC7)=O)C)O)N(C)C

C40H51NO13

753.83

[1]Oki T, et al. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone. J Antibiot (Tokyo) . 1980 Nov;33 (11) :1331-40.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-N14782/

Natural Products

No Development Reported